CG Oncology (CGON) News Today → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free CGON Stock Alerts $30.02 -2.41 (-7.43%) (As of 05/9/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCG Oncology Reports First Quarter 2024 Financial Results and Provides Business Updatesglobenewswire.com - May 9 at 8:00 AMCG Oncology (NASDAQ:CGON) Trading Down 8.1%marketbeat.com - May 8 at 8:00 PMCG Oncology (NASDAQ:CGON) Stock Rating Reaffirmed by HC Wainwrightamericanbankingnews.com - May 8 at 4:58 AMCG Oncology’s Cretostimogene Shows Promising Efficacy and Safety in NMIBC Treatment, Merits Buy Ratingmarkets.businessinsider.com - May 6 at 9:51 PMCG Oncology: ASCO Play And Top-Line Data End Of 2024 Could Drive Further Valueseekingalpha.com - May 6 at 4:50 PMCG Oncology (NASDAQ:CGON) Earns Buy Rating from HC Wainwrightmarketbeat.com - May 6 at 8:07 AMCG Oncology (NASDAQ:CGON) Receives Overweight Rating from Cantor Fitzgeraldamericanbankingnews.com - May 6 at 7:38 AMCG Oncology (NASDAQ:CGON) Shares Up 18.3%americanbankingnews.com - May 5 at 4:34 AMBuy Rating Justified by CG Oncology’s Cretosmogene Efficacy and Market Positioningmarkets.businessinsider.com - May 4 at 3:17 AMCG Oncology reports data from Phase 3 bladder cancer studyseekingalpha.com - May 3 at 10:16 PMCG Oncology's Promising Bladder Cancer Treatment: Balancing Hope And Risk In Late-Stage Trialsseekingalpha.com - May 3 at 3:54 PMCretostimogene Monotherapy Demonstrated 75.2% Complete Response Rate in High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancerglobenewswire.com - May 3 at 11:23 AMCG Oncology's (CGON) Overweight Rating Reiterated at Cantor Fitzgeraldmarketbeat.com - May 2 at 12:24 PMCG Oncology to Host Virtual Investor Event on Friday, May 3, 2024globenewswire.com - April 26 at 8:00 AMFY2024 EPS Estimates for CG Oncology, Inc. Cut by Analyst (NASDAQ:CGON)marketbeat.com - April 25 at 8:31 AMValidea Detailed Fundamental Analysis - CGONnasdaq.com - April 24 at 10:26 PMCG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024globenewswire.com - April 24 at 10:00 AMBuy Rating Affirmed for CG Oncology Amidst Bladder Cancer Treatment Landscape and BCG Shortagemarkets.businessinsider.com - April 23 at 4:25 PMCG Oncology (NASDAQ:CGON) Shares Up 7.9%marketbeat.com - April 23 at 3:43 PMCG Oncology, Inc. (CGON)finance.yahoo.com - April 16 at 2:03 PMCG Oncology (NASDAQ:CGON) Stock Price Down 6%marketbeat.com - April 15 at 5:31 PM20 Countries with the Most Domestically Listed Companies in the Worldmsn.com - April 12 at 12:59 AMEquities Analysts Set Expectations for CG Oncology, Inc.'s FY2024 Earnings (NASDAQ:CGON)marketbeat.com - April 8 at 2:17 AMFY2028 EPS Estimates for CG Oncology, Inc. (NASDAQ:CGON) Raised by Analystmarketbeat.com - April 5 at 9:09 AMCG Oncology Inc (CGON)investing.com - April 5 at 9:04 AMBuy Rating Affirmed for CG Oncology on Strong Clinical Data and Market Potentialmarkets.businessinsider.com - April 5 at 9:04 AMCG Oncology's (CGON) Buy Rating Reaffirmed at HC Wainwrightmarketbeat.com - April 4 at 8:30 AMCG Oncology (NASDAQ:CGON) Stock Price Down 5.1%marketbeat.com - April 3 at 4:50 PMCG Oncology (NASDAQ:CGON) Stock Price Down 5.1%marketbeat.com - April 3 at 4:50 PMBuy Rating Justified by CG Oncology’s Strong Clinical Trial Results and Promising Cretosimogene Therapymarkets.businessinsider.com - April 1 at 2:30 PMCG Oncology to Present Results on Cretostimogene at the AUA 2024 Annual Meetingglobenewswire.com - March 28 at 8:00 AMCG Oncology (NASDAQ:CGON) Shares Gap Down to $39.70marketbeat.com - March 20 at 12:45 PMCG Oncology (NASDAQ:CGON) Stock Price Up 7.1%marketbeat.com - March 19 at 4:48 PMCG Oncology (NASDAQ:CGON) Trading Up 7.1%marketbeat.com - March 13 at 2:58 PMCG Oncology (NASDAQ:CGON) Shares Down 3.9% marketbeat.com - March 1 at 3:14 PMCGON CG Oncology, Inc.seekingalpha.com - March 1 at 9:04 AMBuy Rating Affirmed for CG Oncology, Inc. on Promising CG0070 Phase 3 Trials and Unmet Medical Needmarkets.businessinsider.com - February 28 at 3:51 AMCG Oncology Announces First Patient Dosed in PIVOT-006 Phase 3 Clinical Trial of Cretostimogene in Intermediate-risk Non-Muscle Invasive Bladder Cancerfinance.yahoo.com - February 27 at 12:10 PMCG Oncology (NASDAQ:CGON) Shares Down 7% marketbeat.com - February 23 at 3:59 PMCG Oncology, Inc. (NASDAQ:CGON) to Post FY2023 Earnings of ($1.23) Per Share, Cantor Fitzgerald Forecastsmarketbeat.com - February 23 at 6:34 AMCantor starts CG Oncology at overweight, cites bladder cancer treatmentmsn.com - February 20 at 6:29 PMCG Oncology initiated with neutral view at Goldman Sachs, here's whyrealmoney.thestreet.com - February 20 at 8:28 AMCG Oncology initiated with bullish view at Morgan Stanley, here's whyrealmoney.thestreet.com - February 20 at 8:28 AMCG Oncology, Inc.cnn.com - February 19 at 7:55 AMCG Oncology, Inc. Forecasted to Earn FY2023 Earnings of ($1.23) Per Share (NASDAQ:CGON)marketbeat.com - February 16 at 7:40 AMKairos Pharma sets terms for $6M proposed IPOmsn.com - February 15 at 7:33 PMCG Oncology (NASDAQ:CGON) Now Covered by Analysts at HC Wainwrightmarketbeat.com - February 14 at 7:15 AMCG Oncology (NASDAQ:CGON) Trading Up 9.9%marketbeat.com - February 12 at 12:59 PM3 attractive stocks that insiders are buying insidertrades.com - February 12 at 10:59 AMCG Oncology Inc CGONmorningstar.com - February 9 at 4:45 PM Get CG Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CGON and its competitors with MarketBeat's FREE daily newsletter. Email Address He Is Giving Away Bitcoin (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here CGON Media Mentions By Week CGON Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CGON News Sentiment▼-0.040.39▲Average Medical News Sentiment CGON News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CGON Articles This Week▼144▲CGON Articles Average Week Get CG Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CGON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Arcellx News Today Immunocore News Today Denali Therapeutics News Today Vericel News Today Kymera Therapeutics News Today Apogee Therapeutics News Today Sana Biotechnology News Today SpringWorks Therapeutics News Today Recursion Pharmaceuticals News Today Iovance Biotherapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CGON) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaUrgent Nvidia WarningAltimetryThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CG Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
